A free email with news, trends, and opinion articles about the nonprofit world, as well as links to our tools, resources, and webinars. Delivered every weekday. Philanthropy Today subscribers also get a bonus weekly email called Philanthropy Today — The Commons, about how America’s nonprofits and foundations are working to heal the nation’s divides.
From: Chronicle of Philanthropy
Subject: Stanley McChrystal on How National Service Can Unite America (Opinion)
We are unable to fully display the content of this page.
The most likely cause of this is a content blocker on your computer or network.
Please allow access to our site, and then refresh this page. You may then be asked to log in, create an account if you don't already have one, or subscribe.
If you continue to experience issues, please contact us at 571-540-8070 or cophelp@philanthropy.com
Join our webinar Thursday. See details below.
‘Insider giving’ — donations of stock from large shareholders that happen just before the stock drops in value — is widespread and underregulated, according to a new study. Looking at nearly 10,000 gifts of common stock from 1986 to 2020, researchers found the donated stocks rose by 6 percent on average the year before the gift and fell by an average of 4 percent the year after. The pattern suggests “more than chance,” one researcher said. Instead, it points to “the sharing of material nonpublic information by corporate executives.” Given that the gifts are tax deductible, donors end up with a significant deduction for a “trivial gift.” (Wall Street Journal — subscription)
One father’s quest for a cure for his son’s Type 1 diabetes has led to a $160 million research fund fed by philanthropy and fat investment returns. Sean Doherty began the nonprofit T1D investment fund four years ago, drawing on his experience working for Bain Capital and a rather deep-pocketed network. The minimum donation is $500,000 and returns — so far, $50 million — are plowed back into the fund. Doherty said he wanted to absorb the risk that drug companies are reluctant to take and to get the market to pay attention to the often-overlooked disease. One promising avenue of investment has been stem-cell research, while efforts to create new companies out of early lab work have not panned out. (New York Times)
The Ford and Andrew W. Mellon foundations are giving $5 million directly to Latino artists, a group that typically receives little philanthropy. The Latinx Artist Fellowship will kick off with $50,000 grants to 15 artists, to be parceled out over the next five years. During that same period, administrators of the fund — the US Latinx Art Forum and the New York Foundation for the Arts — will split $3.75 million among 75 artists. Officials with the two funding foundations said Latino artists typically get a small piece of the modest philanthropy dollars that Latino causes in general attract. By one estimate, Latino arts and culture grants fell from $40.2 million in 2013 to $13.4 million in 2019. (New York Times)
